Literature DB >> 20154237

Safety of long-acting beta2-agonists in the management of asthma: a Primary Care Respiratory Alliance of Canada perspective.

Anthony D D'Urzo1, Pieter Jugovic, Jacques Bouchard, Reuven Jhirad, Itamar Tamari.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20154237      PMCID： PMC2821225     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN： 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  14 in total

1.  Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma-related deaths.

Authors:  Shelley R Salpeter; Nicholas S Buckley; Thomas M Ormiston; Edwin E Salpeter
Journal:  Ann Intern Med       Date:  2006-06-05       Impact factor: 25.391

Review 2.  Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids.

Authors:  Pierre Ernst; Andrew McIvor; Francine M Ducharme; Louis-Philippe Boulet; Mark FitzGerald; Kenneth R Chapman; Tony Bai
Journal:  Ann Intern Med       Date:  2006-11-07       Impact factor: 25.391

3.  Risks of long-acting beta-agonists in achieving asthma control.

Authors:  Jeffrey M Drazen; Paul M O'Byrne
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

4.  Effectiveness and safety of salmeterol in nonspecialist practice settings.

Authors:  A D D'Urzo; K R Chapman; A Cartier; F E Hargreave; M Fitzgerald; D Tesarowski
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

5.  Potential masking effects of salmeterol on airway inflammation in asthma.

Authors:  R A Mcivor; E Pizzichini; M O Turner; P Hussack; F E Hargreave; M R Sears
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

6.  The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol.

Authors:  Harold S Nelson; Scott T Weiss; Eugene R Bleecker; Steven W Yancey; Paul M Dorinsky
Journal:  Chest       Date:  2006-01       Impact factor: 9.410

7.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

8.  Inhaled Glucocorticosteroid and Long-Acting beta(2)-Adrenoceptor Agonist Single-Inhaler Combination for Both Maintenance and Rescue Therapy : A Paradigm Shift in Asthma Management.

Authors:  Anthony D D'Urzo
Journal:  Treat Respir Med       Date:  2006

9.  Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study.

Authors:  Eric D Bateman; Homer A Boushey; Jean Bousquet; William W Busse; Tim J H Clark; Romain A Pauwels; Søren E Pedersen
Journal:  Am J Respir Crit Care Med       Date:  2004-07-15       Impact factor: 21.405

10.  Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment.

Authors:  W Castle; R Fuller; J Hall; J Palmer
Journal:  BMJ       Date:  1993-04-17
View more
  1 in total

1.  Cover concerns.

Authors:  Tom Kovesi
Journal:  Can Fam Physician       Date:  2010-04       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.